Arbutus Biopharma News

Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Director BURGESS DANIEL D

May 24 15:24

Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Rewolinski Melissa

May 24 15:22

Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Director MANCHESTER KEITH S

May 24 15:20

Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Meyers James R

May 24 15:19

Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Director HENRIQUES RICHARD C JR

May 24 15:18

Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Torti Frank

May 24 15:13

Arbutus Biopharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Whitefort Capital Master Fund, LP(6.8%),Whitefort Capital GP, LLC(6.8%), etc.

May 17 08:07

Arbutus Biopharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-Whitefort Capital Master Fund, LP(6.8%),Whitefort Capital GP, LLC(6.8%), etc.

May 9 07:02

Arbutus Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Whitefort Capital Management, LP(7.9%),David Salanic(7.9%), etc.

Feb 14 15:46

Arbutus Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Two Seas Capital LP(5.4%),Two Seas Capital GP LLC(5.4%), etc.

Feb 14 09:52

Arbutus Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(6.2%)

Feb 12 08:44

Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Naftzger J. Christopher

Feb 5 18:59

Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Sims Karen

Feb 5 18:59

Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer HASTINGS DAVID C

Feb 5 18:59

Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Sofia Michael J.

Feb 5 18:58

Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer McElhaugh Michael J.

Feb 5 18:58

Arbutus Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Two Seas Capital LP(5.7%),Two Seas Capital GP LLC(5.7%), etc.

Nov 21, 2023 07:00

Arbutus Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Whitefort Capital Management, LP(6.0%),David Salanic(6.0%), etc.

Sep 11, 2023 16:07

Arbutus Biopharma | 4: Statement of changes in beneficial ownership of securities-Director Rewolinski Melissa

Jul 13, 2023 15:13

Arbutus Biopharma | 3: Initial statement of beneficial ownership of securities-Director Rewolinski Melissa

Jul 13, 2023 15:11